Mao, D., Reuter, C. M., Farrow, E. G., Rosenfeld, J. A., Mackenzie, K. M., Küry, S., . . . Chao, H. (2020). De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation. American journal of human genetics, 106(4), 570-583. https://doi.org/10.1016/j.ajhg.2020.02.016
Chicago Style (17th ed.) CitationMao, Dongxue, et al. "De Novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation." American Journal of Human Genetics 106, no. 4 (2020): 570-583. https://doi.org/10.1016/j.ajhg.2020.02.016.
MLA (9th ed.) CitationMao, Dongxue, et al. "De Novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation." American Journal of Human Genetics, vol. 106, no. 4, 2020, pp. 570-583, https://doi.org/10.1016/j.ajhg.2020.02.016.